{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:18:41Z","timestamp":1788153521926,"version":"build-2803163510"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD) is very complex, which has not been fully revealed as so far. This study aimed to identify differentially expressed genes involved in the pathogenesis of MAFLD using Oxford Nanopore Technologies (ONT) transcriptomic sequencing and to investigate the potential role of fatty acid-binding protein 5 (FABP5) in hepatic lipid accumulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Male C57\/BL6N mice with fed either a high-fat, high-fructose (HFHF) diet for 19 weeks to induce MAFLD or a standard chow diet. Liver tissues were subjected to histological examination and ONT transcriptomic analysis and selected differentially expressed genes involved in lipid transport and metabolism were validated by quantitative reverse-transcription PCR (RT-qPCR). Serum FABP5 concentrations were measured in HFHF-fed mice and patients with MAFLD using enzyme-linked immunosorbent assay (ELISA).\n                      <jats:italic>In vitro<\/jats:italic>\n                      , Huh-7 cells were treated with different concentrations of palmitic acid (PA) to induce lipid accumulation. FABP5 was subsequently overexpressed in PA-treated cells, followed by assessment of intracellular lipid accumulation and the expression of genes involved in fatty acid oxidation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      HFHF-fed mice exhibited marked hepatic steatosis, hepatocyte ballooning, and lobular inflammation. ONT transcriptomic analysis identified 400 differentially expressed genes between the HFHF and chow groups, including 12 genes involved in lipid transport and metabolism. RT-qPCR validation showed that hepatic\n                      <jats:italic>Fabp5<\/jats:italic>\n                      expression was significantly decreased in HFHF-fed mice, consistent with the ONT sequencing results. Serum FABP5 concentrations were significantly lower in HFHF-fed mice and patients with MAFLD than in their respective controls. PA treatment induced intracellular lipid accumulation in Huh-7 cells in a concentration-dependent manner. FABP5 overexpression attenuated PA-induced lipid accumulation and increased\n                      <jats:italic>PPAR\u03b1<\/jats:italic>\n                      expression, together with changes in other genes associated with fatty acid oxidation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Hepatic\n                      <jats:italic>Fabp5<\/jats:italic>\n                      expression and circulating FABP5 concentrations are reduced in experimental and human MAFLD. Restoration of FABP5 attenuates PA-induced lipid accumulation in hepatocyte-derived cells and is accompanied by increased expression of\n                      <jats:italic>PPAR\u03b1<\/jats:italic>\n                      and other fatty acid oxidation-related genes. These findings suggest that FABP5 is a candidate regulator of hepatic lipid metabolism and warrants further investigation as a potential therapeutic target for MAFLD. Additional inhibition and rescue experiments are required to determine whether PPAR\u03b1 is a necessary mediator of the lipid-lowering effect of FABP5.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1883460","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:29:06Z","timestamp":1788150546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic analysis identifies FABP5 as a candidate regulator of lipid accumulation in metabolic dysfunction-associated fatty liver disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Kaishuo","family":"Lv","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Henan Provincial People\u2019s Hospital, People's Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Stanford University School of Medicine","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu (Daisy)","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Stanford University School of Medicine","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology,Henan Provincial People\u2019s Hospital, People's Hospital of Zhengzhou University","place":["Zhengzhou, China"]},{"name":"Department of Gastroenterology and Hepatology, Stanford University School of Medicine","place":["Palo Alto, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036663","article-title":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1291501","article-title":"Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies","volume":"11","author":"Habibullah","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B15","article-title":"Development and validation of a gene-level molecular disease activity and fibrosis score for nonalcoholic fatty liver disease","volume":"68","author":"Hoang","year":"2018","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/642612","article-title":"Lipid chaperones and metabolic inflammation","volume":"2011","author":"Furuhashi","year":"2011","journal-title":"Int J Inflam"},{"key":"B17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs--mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2020.07.027","article-title":"Snapshot: FABP functions","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-5-3-170","article-title":"The human fatty acid-binding protein family: evolutionary divergences and functions","volume":"5","author":"Smathers","year":"2011","journal-title":"Hum Genomics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m111.304907","article-title":"Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors","volume":"287","author":"Kaczocha","year":"2012","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1107\/s1399004713026795","article-title":"Crystallographic study of FABP5 as an intracellular endocannabinoid transporter","volume":"70","author":"Sanson","year":"2014","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07245.x","article-title":"Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells","volume":"117","author":"Mitchell","year":"2011","journal-title":"J Neurochem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.113.301588","article-title":"Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle","volume":"33","author":"Iso","year":"2013","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12899-019-0038-6","article-title":"Exercise endurance capacity is markedly reduced due to impaired energy homeostasis during prolonged fasting in FABP4\/5 deficient mice","volume":"19","author":"Iso","year":"2019","journal-title":"BMC Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415846","article-title":"Asprosin-FABP5 interaction modulates mitochondrial fatty acid oxidation through PPARalpha contributing to MASLD development","volume":"12","author":"Yu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacl.2015.12.012","article-title":"Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders","volume":"10","author":"Ibarretxe","year":"2016","journal-title":"J Clin Lipidol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.575557","article-title":"Independent and distinct associations of FABP4 and FABP5 with metabolic parameters in type 2 diabetes mellitus","volume":"11","author":"Furuhashi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41598-017-00177-w","article-title":"Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages","volume":"7","author":"Furuhashi","year":"2017","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.m065896","article-title":"Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2-\/-) or obese (ob\/ob) mice","volume":"57","author":"Agarwal","year":"2016","journal-title":"J Lipid Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000194r","article-title":"Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model","volume":"34","author":"de Conti","year":"2020","journal-title":"FASEB J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci85499","article-title":"Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease","volume":"127","author":"Stein","year":"2017","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2017.07.007","article-title":"Regulation of lipid droplet-associated proteins by peroxisome proliferator-activated receptors","volume":"1862","author":"de la Rosa Rodriguez","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.15698\/mic2018.02.614","article-title":"Fat storage-inducing transmembrane (FIT or FITM) proteins are related to lipid phosphatase\/phosphotransferase enzymes","volume":"5","author":"Hayes","year":"2017","journal-title":"Microb Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12864-020-06837-y","article-title":"Protein acetylation in mitochondria plays critical functions in the pathogenesis of fatty liver disease","volume":"21","author":"Le-Tian","year":"2020","journal-title":"BMC Genomics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2016.01010","article-title":"Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis","volume":"5","author":"Schroder","year":"2016","journal-title":"Mol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.857919","article-title":"The biological functions and regulatory mechanisms of fatty acid binding protein 5 in various diseases","volume":"10","author":"Xu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2777","article-title":"Proteomic analysis of the INS-1E secretome identify novel vitamin D-regulated proteins","volume":"32","author":"Pepaj","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167825","article-title":"Transcriptome and metabolome analyses in exogenous FABP4- and FABP5-treated adipose-derived stem cells","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J Hepatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.06.001","article-title":"Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages","volume":"67","author":"Moore","year":"2015","journal-title":"Mol Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70262","article-title":"A conserved FABP5(high) macrophage subset promotes fibrosis and carcinogenesis in advanced liver disease","volume":"45","author":"Ge","year":"2025","journal-title":"Liver Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200182","article-title":"FABP5 deficiency impaired macrophage inflammation by regulating AMPK\/NF-kappaB signaling pathway","volume":"209","author":"Hou","year":"2022","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/nu9101072","article-title":"Animal models of nonalcoholic fatty liver disease-a starter's guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519833527","article-title":"Pathogenesis of and major animal models used for nonalcoholic fatty liver disease","volume":"47","author":"Jiang","year":"2019","journal-title":"J Int Med Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.gastro.2016.05.051","article-title":"Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients","volume":"151","author":"Teufel","year":"2016","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPARalpha","volume":"3","author":"Kersten","year":"2014","journal-title":"Mol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.nutr.21.1.193","article-title":"Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system","volume":"21","author":"Reddy","year":"2001","journal-title":"Annu Rev Nutr"},{"key":"B52","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPARalpha in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur J Biochem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/jci0215715","article-title":"Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle","volume":"110","author":"Rasmussen","year":"2002","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.10.008","article-title":"Role of malonyl-CoA in heart disease and the hypothalamic control of obesity","volume":"73","author":"Folmes","year":"2007","journal-title":"Cardiovasc Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"8794","DOI":"10.1038\/ncomms9794","article-title":"Saturated fatty acids regulate retinoic acid signalling and suppress tumorigenesis by targeting fatty acid-binding protein 5","volume":"6","author":"Levi","year":"2015","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9104-8","article-title":"The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results","volume":"33","author":"Wanders","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/0471140856.tx2503s60","article-title":"Assessment of fatty acid beta oxidation in cells and isolated mitochondria","volume":"60","author":"Rogers","year":"2014","journal-title":"Curr Protoc Toxicol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjab018","article-title":"Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells","volume":"13","author":"Duan","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202052122","article-title":"Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress","volume":"22","author":"Yan","year":"2021","journal-title":"EMBO Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3423","article-title":"Three decades of nanopore sequencing","volume":"34","author":"Deamer","year":"2016","journal-title":"Nat Biotechnol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1883460\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T04:29:07Z","timestamp":1788150547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1883460\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":61,"alternative-id":["10.3389\/fendo.2026.1883460"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1883460","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"1883460"}}